NEUROCRINE BIOSCIENC

NBIX
Delayed Quote. Delayed  - 12/07 04:00:00 pm
82.25USD +1.93%

Turn to zoom
Prev.82.2500
Open80.6900
High82.9800
Low80.6900
Volume980 257
Latest news
5h ago
6h ago
7d ago
7d ago
Chart NEUROCRINE BIOSCIENCES, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance89,689,695,0
Spread/Res.-8,2%-8,2%-13%
Spread/Supp.3,2%3,2%3,2%
Support79,779,779,7
Financials
Sales 2021 1 141 M - -
Net income 2021 156 M - -
Net cash 2021 991 M - -
P/E ratio 2021 51,7x
Yield 2021 -
Capitalization 7 803 M 7 803 M -
EV / Sales 2021 5,97x
EV / Sales 2022 4,48x
Nbr of Employees 917
Free-Float 98,1%
Company
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is focused on discovering, developing, and delivering treatments for people with neurological, endocrine and psychiatric disorders. Its portfolio includes treatments for tardive dyskinesia, Parkinson’s...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2022-02-08 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 82,25 $
Average target price 121,34 $
Spread / Average Target 47,5%